Literature DB >> 17804956

Public opinion about Alzheimer disease among blacks, hispanics, and whites: results from a national survey.

Cathleen M Connell1, J Scott Roberts, Sara J McLaughlin.   

Abstract

Recent research has documented notable differences in knowledge, awareness, and cultural beliefs about Alzheimer disease (AD) among groups defined by race and ethnicity. The present study was conducted to assess racial differences in knowledge and attitudes about AD among a national sample of adults. Data from 1,176 adults aged 35 years and over (48.6% White, 25.7% Black, and 25.8% Hispanic) obtained via telephone interview were used in this study. Although some notable group differences defined by race/ethnicity were observed, more similarities in patterns of response were discovered than expected. Black and Hispanic respondents were significantly more likely to believe that AD is a normal part of aging, but were more optimistic about future advances in research than White participants. Compared with White and Black respondents, Hispanics were more likely to report feeling well-prepared for handling a diagnosis of AD in a family member. Overall, the results suggest that misconceptions about AD remain among large segments of the population, that AD remains a source of significant concern, and that continued efforts are needed to educate the public about this disease.

Entities:  

Mesh:

Year:  2007        PMID: 17804956     DOI: 10.1097/WAD.0b013e3181461740

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  44 in total

1.  Do general practitioners recognize mild cognitive impairment in their patients?

Authors:  H Kaduszkiewicz; T Zimmermann; H Van den Bussche; C Bachmann; B Wiese; H Bickel; E Mösch; H-P Romberg; F Jessen; G Cvetanovska-Pllashniku; W Maier; S G Riedel-Heller; M Luppa; H Sandholzer; S Weyerer; M Mayer; A Hofmann; A Fuchs; H-H Abholz; M Pentzek
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Pharmacological treatment of Alzheimer's disease: effect of race and demographic variables.

Authors:  Santiago Hernandez; McKee J McClendon; Xiao-Hua Andrew Zhou; Michael Sachs; Alan J Lerner
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

3.  Predictors of physician referral for patient recruitment to Alzheimer disease clinical trials.

Authors:  James E Galvin; Thomas M Meuser; Linda Boise; Cathleen M Connell
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Oct-Dec       Impact factor: 2.703

4.  Learning from recruitment challenges: barriers to diagnosis, treatment, and research participation for Latinos with symptoms of Alzheimer's disease.

Authors:  Caroline Rosenthal Gelman
Journal:  J Gerontol Soc Work       Date:  2010-01

Review 5.  Knowledge evaluation instruments for dementia caregiver education programs: A scoping review.

Authors:  Nicholas V Resciniti; Weizhou Tang; Masroora Tabassum; Joseph Lee Pearson; Sharon Melinda Spencer; Matthew C Lohman; Diane K Ehlers; Dana Al-Hasan; Maggi C Miller; Ana Teixeira; Daniela B Friedman
Journal:  Geriatr Gerontol Int       Date:  2020-03-04       Impact factor: 2.730

6.  Cultural diversity and views on Alzheimer disease in older African Americans.

Authors:  Barry W Rovner; Robin J Casten; Lynn F Harris
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Apr-Jun       Impact factor: 2.703

7.  Public beliefs and knowledge about risk and protective factors for Alzheimer's disease.

Authors:  J Scott Roberts; Sara J McLaughlin; Cathleen M Connell
Journal:  Alzheimers Dement       Date:  2014-03-14       Impact factor: 21.566

8.  Perceptions of Risk Factors for Alzheimer Disease Among Community-Dwelling, Nondemented Older African Americans.

Authors:  Crystal M Glover; Shelytia CoCroft; Bryan D James; Lisa L Barnes
Journal:  Alzheimer Dis Assoc Disord       Date:  2019 Jul-Sep       Impact factor: 2.703

9.  Memantine and acetylcholinesterase inhibitor treatment in cases of CDR 0.5 or questionable impairment.

Authors:  McKee J McClendon; Santiago Hernandez; Kathleen A Smyth; Alan J Lerner
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

10.  Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals.

Authors:  Matthias W Riepe; Thomas Mittendorf; Hans Förstl; Lutz Frölich; Martin Haupt; Reiner Leidl; Christoph Vauth; Matthias Graf von der Schulenburg
Journal:  BMC Neurol       Date:  2009-08-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.